May 04, 2023 - Thursday | ||
Prof. Henry Krum Room | Hall B | |
13:00-14:30 | Registration | |
15:00-15:30 | Opening Speeches |
|
15:30-16:30 | Global Burden of Heart Failure in My Country Turkey Iran Asia and Azerbaijan Indonesia Europe |
|
16:30-17:00 | Coffee Break | |
17:00-18:00 | Corse-1: Cardiac Biopsy Dr. Heinz-Peter Schultheiss, Dr. Barış Okçun, Dr. Hakan Altay |
|
May 05, 2023 - Friday | ||
Prof. Henry Krum Room | Hall B | |
08:30-09:30 |
|
Abstract Session-1 OA-1: Medical Treatment in Patients with Chronic Heart Failure: Who Is Responsible for Poor Adherence? OA-2: Empowerment Program Effect On Self-Care Behaviors and Readmission in Heart Failure Patients: A Randomized Controlled Trial OA-3: Our Experience with Sacubitril/Valsartan in Chronic Heart Failure Management - HFREF in The Ambulatory Setting OA-4: Relationship Between Iron Levels and Heart Failure Related Events in Patients with ST-segment Elevation Myocardial Infarction |
09:30-10:30 | Prevention and Awareness of Heart Failure Public Awareness of Heart Failure in 7 Continents of World Primary Care Management of Heart Failure with Preserved Ejection Fraction Prevention of Cancer Therapy-Related Heart Failure Dr. Cafer Zorkun (TR) |
|
10:30-11:00 | Coffee Break | |
11:00-11:30 |
Satellite Symposium ![]() |
|
11:30-12:30 | Diagnosis and Risk Stratification New Framework for Application of Cardiac Imaging to Patients with Heart Failure Ejection Fraction and Clinical Phenotypes of Heart Failure Biomarkers in Heart Failure with Preserved Ejection Fraction |
Abstract Session-2 OA-5: Artificial Intelligence for Prediction of Chronic Thromboembolic Pulmonary Hypertension Using Electrocardiography OA-6: Artificial Intelligence for Prediction of Pulmonary Arterial Hypertension Detection Using Computer Tomography OA-7: Non-Ischemic Cardiomyopathy Patient's Characteristics, Achievement of Optimal Medical Treatment Doses, And Prognosis in Age Tertiles. OA-8: Determination of The Discordance Between Right and Left Ventricular Filling Pressures by Clinical Examination in Patients with Pulmonary Hypertension and Right Ventricular Heart Failure |
12:30-14:00 | Lunch | |
14:00-15:00 | Recent Advances in Treatment of Heart Failure 4 Stars in Drug Therapy of Heart Failure Atrial Fibrillation and Heart Failure: Rhythm Control Versus Rate Control Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose |
|
15:00-15:30 | Satellite Symposium: Deva Dr. Tarık Kıvrak (TR), Dr. Berkay Ekici (TR) |
|
15:30-15:45 | Coffee Break | |
15:45-16:45 | Renal Functions and Volume-Guided Management in Heart Failure Management of Volume Overload in AHF Managing Heart Failure in Patients on Dialysis Hyponatremia |
|
16:45-17:45 | Devices and Surgical Procedures in Heart Failure Transcatheter Interatrial Shunts for Heart Failure CRT, Cardiac Contractility Modulation Current and Future Directions of Coronary Revascularization in Patients with Heart Failure |
May 06, 2023 - Saturday | ||
Prof. Henry Krum Room | Hall B | |
08:30-09:30 | Meet the Experts: CTEPH How to correctly diagnose CTEPH? Medical treatment in CTEPH? Pulmonary Endarterectomy Experience in Iran Pulmonary Endarterectomy in Türkiye Post-operative follow up |
|
09:30-10:30 | Heart Failure and Cardiomyopathies International Registry of COVID-19-Induced Myocarditis, Cardiomyopathy and Heart Failure (ISCMF registry) Cardiac Amiloidosis Heart Failure in Hypertrophic Cardiomyopathy Dr. Elif Eroğlu Büyüköner (TR) |
|
10:30-11:15 | Coffee Break | |
11:15-12:15 | Pulmonary Hypertension New Guideline for PH Imaging in PAH Management of non-cardiac complication in PAH? Dr. Negin Molazadeh (IR) |
Abstract Session-3 OA-9: The Favorable Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Chronic Heart Failure Patients - The Fourth Pillar of Heart Failure Management. OA-10: The Effect of Sodium Glucose Co-Transporter-2 Inhibitors On Systemic Immune Inflammatory Index Levels in Heart Failure with Reduced Ejection Fraction OA-11: The Relationship Between Coronary Artery Tortuosity and H2FPEF Score |
12:15-13.15 | Acute Heart Failure Pathophysiology of the Transition from Chronic Compensated and Acute Decompensated Heart Failure Cardiorenal Syndrome Type 2 Temporary Mechanical Circulatory Support in Acute Heart Failure Dr. Ümit Kervan (TR) |
Abstract Session-4 OA-12: Late Migration and Embolization of an Occluder Device for Atrial Septal Defect in to The Abdominal Aorta: A Case Report OA-13: Prophylactic Legal Measures for Medical Malpractice Stress Syndrome OA-14: The Impact of Naples Prognostic Score On Mid-term All-cause Mortality İn Heart Failure OA-15: A Clinical Nomogram Based On Systemic İmmune İnflammation Response İndex to Predict Long-term Mortality İn ST-segment Elevation Myocardial İnfarction Patients |
13:15-14:00 | Lunch | |
14:00-15:00 | Coronary Artery Disease and Revascularization in Heart Failure Imaging for Hibernating Myocardium SGLT 2 Inhibitors Beyond Heart failure Chronic Total Occlusion Percutaneous Coronary Interventions in HF patients: Rain or Shine? |
Abstract Session-5 OA-16: Incidentally detected Giant Aneurysmal Type Renal Arteriovenous Fistula Resulting Reversible Biventricular Dilatation and Mildly Reduced Left Ventricle Systolic Function OA-17: Dasatinib and Pulmonary Arterial Hypertension: What Can We Do? Stop The Treatment or Wait the Recurrence of Leukemia OA-18: ITGA2 Integrin Gene Polymorphism in Patients with Hypertension and Ischemic Heart Disease in Azerbaijan OA-19: Repeat Revascularization During Covid-19 Pandemic: A Comparative Analysis of Efficacy and Safety of PCI and CABG Procedures |
15:00-15:15 | Coffee Break | |
15:15-16:15 | Yellow Boxes in Heart Failure (IIa and IIb of Guideline Recommendations) Soluble Guanylate Cyclase Receptor Stimulators in Patients with HFrEF Recommendations for Cardiac Resynchronization Therapy Implantation in Patients with Heart Failure Treatments for Patients with Heart Failure with Mildly Reduced Ejection Fraction Dr. Mehriban İsgəndər (AZ) |
Abstract Session-6 OA-20: SARS-COV-2 Infection and Heart Transplantation OA-21: Evaluation of Thrombosis and Bleeding Events in Children with Implanted Left Ventricular Assist Device OA-22: Left Ventricular Outflow Tract Presystolic Wave May Disappear as Myocyte Injury Progresses in Patients with Hypertension OA-23: The Effect of Covid-19 Vaccination in Heart Transplant Recipients OA-24: A Rare Case of Primary Cardiac Malignant Fibrous Histiocytoma Presenting as Right Heart Failure |
16:15-16:30 | Coffee Break | |
16:30-17:30 | Post-Discharge and Follow-Up Telemonitoring and Artificial Intelligence Pulmonary Artery Catheter Monitoring Vasculartoxicity and Heart Failure |
May 07, 2023 - Sunday | ||
Prof. Henry Krum Room | Hall B | |
08:30-09:30 |
|
Corse-2: Left Ventricular Assist Devices |
09:30-10:30 | Controversy in Management of Heart Failure Indonesia Heart Failure Society Joint Session Comparison Between Recommendations by the Last ESC and ACC/AHA/HFSA Guidelines Salt Restriction in Heart failure Complementary and Alternative Medicines in the Management of Heart Failure |
|
10:30-11:30 | Advance Heart Failure Updated Definition of Advanced Chronic Heart Failure The Impact of Worsening Heart Failure and New Therapies Management of Non-responders to Cardiac Resynchronisation Therapy |
|
11:30-12:00 | Closing Remarks Dr. Bambang Budi Siswanto (ID) |